Engflag

Erix

Quick links to important sections

Erix

There is no image.

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Erix

Quick Facts

Property Description
Active ingredient Sildenafil Citrate
Form Tablet, Oral Suspension/Solution
Pharmacological class Phosphodiesterase type 5 (PDE5) inhibitor
General Purpose Targeted vasodilation/Improved blood flow
Origin Synthetic compound

What is Erix? Core Definition and Composition

Erix is a proprietary medicine containing the active ingredient Sildenafil Citrate, which serves as a highly specific enzyme inhibitor. This compound is a synthetic substance designed for oral administration, typically available in several high-level dosage forms, including the tablet, film-coated tablet, oral suspension, and oral solution. As a single-component medicine, its composition relies solely on Sildenafil Citrate, combined with either solid excipients or an appropriate liquid vehicle to facilitate reliable delivery. The substance Sildenafil is a pyrazolopyrimidinone derivative created through chemical synthesis.

The Pharmacological Type: Erix as a PDE5 Inhibitor

Erix belongs to the distinct pharmacological class of Phosphodiesterase type 5 (PDE5) inhibitors, a classification that defines its core action. This means the medicine functions by selectively blocking the action of the PDE5 enzyme in specific smooth muscle tissues. This selective inhibition is characterized by its ability to modulate the circulatory system.

General Purpose of the Vasodilator Action

The resulting physiological effect of the drug is targeted vasodilation—the widening of specific blood vessels—which facilitates a necessary increase in local blood flow. This action serves the general therapeutic objective of overcoming conditions characterized by restricted blood supply or abnormally elevated vascular pressure. The mechanism is dependent upon the specific inhibition of cGMP hydrolysis, which confirms the core mechanism's link to the medicine's broad benefit: promoting muscle relaxation in the vascular walls to achieve enhanced circulation.

What side effects are possible with Erix?

Possible side effects and safety information

The official safety profile for Erix (Sildenafil Citrate) classifies possible adverse reactions based on their observed frequency and the physiological system affected, strictly following government regulatory standards. These classifications reflect how regulatory documents organize and communicate the medicine’s safety profile.

Frequency-Classified Adverse Reactions

The following are examples of adverse reactions listed according to official frequency categories:

Classification Examples of Reactions
Very Common (ge 1/10) Headache
Common (ge 1/100 to < 1/10) Flushing, Dyspepsia, Nasal congestion, Visual disturbances (e.g., blurred vision)

Some of the more common effects, such as headache and flushing, are frequently observed at the initiation of treatment or following dose escalation, a pattern noted in the regulatory documents.

System-Organ Classes and Serious Reactions

Adverse effects are also grouped by System-Organ Class (SOC), covering domains like Nervous System Disorders, Vascular Disorders, and Eye Disorders.

Regulatory documentation highlights specific serious adverse reactions. These include reports of Priapism (a prolonged erection lasting ge 4 hours), sudden decrease or loss of vision (such as Non-arteritic Anterior Ischemic Optic Neuropathy [NAION]), and sudden decrease or loss of hearing. Reports of serious cardiovascular events, including myocardial infarction and stroke, have been noted in temporal association with use.

Population-Specific Safety Notes

Official labeling notes specific safety considerations for certain patient groups. In older adults (aged 65 and over) and those with severe hepatic or renal impairment, plasma clearance is typically reduced, which may lead to increased systemic exposure. For pediatric patients being treated for Pulmonary Arterial Hypertension (PAH), high doses have been associated with a higher mortality risk and do not improve efficacy compared to lower doses, as stated in regulatory safety data.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Erix

Domain Official Regulatory Statements
Documented overdose presentations Overdose symptoms are consistent with an exaggeration of the drug's known actions, reported in studies using doses higher than recommended. Manifestations include an increased incidence of headache, flushing, dyspepsia, and specific visual disturbances (e.g., changes in color vision, blurred vision) [1.1].
Physiological systems affected Systems documented in the label include the Vascular System (e.g., hypotension, flushing), Ocular System (e.g., sudden vision loss), Auditory System (e.g., sudden hearing loss), and Genitourinary System (e.g., priapism) [1.3].
Dose-related factors Doses higher than the recommended maximum have been associated with increased frequency of adverse events [1.1]. Regulatory warnings also note that higher than recommended doses in pediatric patients with Pulmonary Arterial Hypertension (PAH) were associated with increased mortality [3.4].
Population-specific overdose notes Reduced drug clearance may lead to increased plasma exposure in patients with severe renal or hepatic impairment, potentially increasing the risk of adverse events [2.1].
Emergency-response statements Management involves symptomatic and supportive treatment [1.1]. Regulatory documents note that renal dialysis is not expected to accelerate clearance due to high plasma protein binding [1.1]. No specific antidote is known [1.1].
When immediate medical help is required Call a doctor or go to the nearest emergency room right away for accidental overdose [1.3]. Seek immediate medical assistance if an erection persists longer than 4 hours (priapism), which can result in permanent loss of potency [1.5]. Seek immediate medical attention for sudden loss of vision or sudden decrease or loss of hearing [1.2].

Resulting Overdose Structure

Official overdose statements:

  • The official label documents that overdose may present with an increased frequency of adverse reactions, including headache, flushing, dyspepsia, and visual disturbances, consistent with exaggerated pharmacological effects [1.1].
  • Immediate medical assistance is required if an erection lasts longer than 4 hours, which is a severe complication documented in regulatory warnings that can lead to permanent loss of potency [2.1].
  • Regulatory guidance mandates seeking immediate medical attention for accidental overdose and for the sudden onset of severe sensory symptoms, such as the sudden loss of vision or hearing [1.3, 1.2].
  • Overdose management is defined by the use of symptomatic and supportive treatment; authoritative sources state that renal dialysis is not expected to be beneficial due to the drug’s properties [1.1].

Connection to the overall overdose profile:

Regulatory documents define the overdose profile primarily through the reporting of dose-dependent, exaggerated pharmacological adverse events observed in clinical studies and critical, life-threatening complications reported post-marketing (e.g., priapism, sudden vision loss). The profile strictly instructs that symptomatic and supportive treatment is the management protocol, and it explicitly establishes clear, non-negotiable thresholds (such as an erection lasting ge 4 hours) as triggers for when immediate medical help must be sought.

Therapeutic Uses of Erix

What Erix Treats: Main Uses and Benefits

Erix (Sildenafil Citrate) is commonly used to help with two distinct types of vascular health issues, providing supportive relief for symptoms stemming from impaired circulation in specific organs. This application is relevant in contexts marked by increased discomfort or tension.

The medicine is applied across therapeutic domains involving Erectile Dysfunction (ED) and Pulmonary Arterial Hypertension (PAH). The medicine is relevant for managing symptoms that create noticeable physiological strain in these areas.

Easing Functional Impairment in Erectile Dysfunction

This medication is generally used to help with ED, which involves symptoms related to physical discomfort and functional inability—specifically, the challenge of achieving or sustaining an erection for sexual activity. It is applied across domains where additional symptomatic support is needed, including for patients whose ED symptoms are linked to co-morbidities like diabetes mellitus or certain pelvic surgeries. The key benefit is that it assists with maintaining functional stability, which helps men cope more steadily with symptom fluctuations and contributes to improved comfort related to sexual activity.

“The supportive benefit is aimed at helping patients manage the physical symptoms that interfere with functional stability, which is especially important in chronic conditions.”

Managing the Symptom Burden of Pulmonary Arterial Hypertension

Erix is considered relevant for managing symptoms of PAH, a condition marked by increased physiological stress due to high pressure in the lungs’ blood vessels. It helps address symptom clusters that create noticeable physiological strain, such as shortness of breath and fatigue. By addressing the symptoms of increased physiological stress, the medicine generally supports exercise capacity and physical endurance, assisting with maintaining functional stability and helping to maintain a sense of stability when symptoms are more noticeable. This use is also relevant for managing this condition in pediatric patients over one year of age.

Quick Fact: Supportive Management for Functional Strain

Symptom Type Condition Category Supportive Benefit
Physical discomfort, functional strain Erectile Dysfunction (ED) Supports functional stability and comfort
Noticeable physiological strain, fatigue Pulmonary Arterial Hypertension (PAH) Supports physical endurance and functional capacity

Regulatory References

  1. NIH MedlinePlus overview of Sildenafil

Eligibility and Restrictions for Use

Eligibility and Contraindication Profile

The eligibility for Erix (Sildenafil Citrate) is strictly defined by regulatory authorities based on a patient’s health status and concurrent medications. The medicine is contraindicated and must not be used by patients receiving any form of organic nitrate or nitric oxide donor, or those concurrently using guanylate cyclase (GC) stimulators (e.g., riociguat). Use is also strictly prohibited for individuals with a known hypersensitivity to the drug.

Contraindications also apply to specific medical conditions, including a recent history of stroke or myocardial infarction (within six months), severe hepatic impairment (as noted in some official labels), and specific hereditary degenerative retinal disorders.

Eligibility by age and indication varies. The Erectile Dysfunction indication is established for adult men (ge 18 years). The Pulmonary Arterial Hypertension indication is established for adults and pediatric patients (1 to 17 years old), though chronic use in pediatric patients is often not recommended due to associated risks. Special consideration is required for geriatric patients (ge 65 years) and those with severe renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Erix (Sildenafil Citrate) has officially documented interaction patterns primarily concerning its effects on blood pressure and its clearance by liver enzymes.

Interaction Classifications and Restrictions

Classification Constraint / Affected Substances
Formal Contraindication Co-administration is prohibited with all forms of nitrates (e.g., nitroglycerin, isosorbide dinitrate) and the guanylate cyclase stimulator Riociguat, due to the risk of severe, potentially life-threatening hypotension.
Pharmacodynamic Risk Co-administration with alpha-blockers (e.g., Tamsulosin, Doxazosin) or other anti-hypertensives may result in an officially documented additive reduction in systemic blood pressure.

Pharmacokinetic and Timing Constraints

Sildenafil is cleared predominantly by the liver enzymes CYP3A4 and, to a lesser extent, CYP2C9. Inhibitors of these enzymes significantly alter drug exposure.

  • Exposure-Increasing Interactions: Strong CYP3A4 Inhibitors (e.g., Ritonavir, Ketoconazole, Erythromycin) increase Sildenafil plasma concentration. The maximum single dose is restricted to 25 mg over 48 hours when co-administered with Ritonavir.
  • Exposure-Decreasing Interactions: CYP3A4 Inducers (e.g., Bosentan, Rifampin) can decrease Sildenafil plasma exposure.
  • Food Interaction: Taking Erix with a high-fat meal results in an officially documented reduced rate of absorption and a lower peak plasma concentration.
  • Population Note: Clearance is documented as reduced in patients with severe hepatic impairment (Child-Pugh Class C), which may necessitate dose consideration when combining Erix with interacting medicines.

Mechanism of Action

The mechanism of Erix (Sildenafil Citrate) focuses on a precise molecular intervention within the body’s vascular signaling system, which leads directly to increased local blood flow.

️ Selective Inhibition of the PDE5 Enzyme

The primary action of Erix is the highly selective competitive inhibition of the Phosphodiesterase type 5 (PDE5) enzyme. This enzyme typically hydrolyzes cyclic Guanosine Monophosphate (cGMP), a critical cellular signaling molecule. By blocking PDE5, the drug causes cGMP to accumulate within vascular smooth muscle cells, thereby preserving the action of the natural signal for relaxation.

Augmentation of the NO-cGMP Pathway

The drug acts as an enhancer in the Nitric Oxide (NO) signaling pathway, which is responsible for regulating vascular tone. The elevated cGMP levels trigger a cascade that promotes the reduction of intracellular calcium, leading directly to the relaxation of arterial smooth muscle. This molecular chain translates into targeted vasodilation and a resultant increase in localized blood flow.

Dosage and Administration Information

How to Use Erix — Official Administration Guidelines

The medicine is administered via the oral route (tablet or suspension) and by intravenous (IV) bolus injection for specific uses.

Use Protocol Dosing & Frequency Contextual Constraints
As-Needed Use Initial oral dose is 50 mg, adjustable between 25 mg and 100 mg maximum, taken once per day. Take with or without food; onset may be delayed by high-fat meals.
Continuous Use Standard oral dose is 20 mg three times a day (TID), which may be titrated up to 80 mg TID. IV dose is 10 mg TID. Doses must be spaced 4 to 6 hours apart.

A lower 25 mg oral starting dose should be considered for older adults or for patients with severe renal or hepatic impairment. When co-administered with Ritonavir, the dose must not exceed 25 mg within a 48-hour period. If a maintenance dose is missed, take it as soon as remembered, but skip it if the next dose is near; do not take a double dose. The powder for oral suspension requires reconstitution with water and must be measured using a calibrated device.

These frameworks define the approved routes of administration and set mandatory dose adjustments based on factors like age or the co-administration of specific other medicines, establishing the standardized administration protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Erix

This section outlines the structure of the clinical research that has explored Erix (Sildenafil Citrate), focusing on the types of studies conducted, the specific outcomes they were designed to measure, and what remains uncertain according to official scientific sources. This is a descriptive summary of the evidence landscape and is not clinical guidance.

Evidence for Use in Erectile Dysfunction (ED)

The core research for Erix in adult males with Erectile Dysfunction (ED) primarily consists of short-term randomized, controlled trials (RCTs). These studies was studied for how it compared to a placebo in men experiencing symptoms related to functional ability. The trials were designed to observe differences in reported outcomes reflecting daily functioning or activity level, using patient-reported tools. Short-term trials reported measurements of patient-reported scores on functional ability scales compared to placebo groups. Research highlights that data for certain high-risk patient subgroups remain insufficient, and follow-up durations were limited in many controlled trials.

Evidence for Use in Pulmonary Arterial Hypertension (PAH)

For Pulmonary Arterial Hypertension (PAH), randomized, controlled trials have also been the primary type of research. Erix was evaluated in adult patients with high pressure in the lung's blood vessels. Research examined outcomes monitoring physiological strain or stress, focusing particularly on functional measures like exercise capacity and changes in overall functional status. Dedicated studies was evaluated in the pediatric population (children over one year of age). Findings describe patterns related to changes measured during the study period, such as in the 6-minute walk test. Evidence is limited for patients in the most severe functional classes or those with advanced co-existing heart or liver conditions, and the question of long-term effects are not fully established remains relevant.

Gaps in Evidence and Ongoing Research

Scientific assessment highlights several limitations. The comparative evidence is lacking for direct, head-to-head trials against all other established treatments for both ED and PAH. Furthermore, for both indications, many key findings rely heavily on patient-reported outcomes describing perceived discomfort and functional changes. Therefore, research is ongoing in many of these areas to provide a more comprehensive understanding of the long-term patterns and subgroup responses. Studies help show what has been observed so far, but findings describe group patterns, not personal outcomes.

Key Studies & References

  1. NIH MedlinePlus overview of Sildenafil
  2. European Medicines Agency (EMA): Sildenafil Public Assessment Report (PAR)

Frequently Asked Questions (FAQ)

Common questions about Erix (FAQ)

Q: How long does it typically take to notice the effects of Erix?

A: Studies on Erix indicate that the maximum concentration of the drug in the blood is typically reached within 30 to 120 minutes after taking an oral dose when fasting. Official product information notes that taking the medicine with a high-fat meal may lead to a delay in the onset of action.

Q: What happens if a dose of Erix is missed?

A: For continuous use protocols, regulatory documents describe the instruction that if a patient forgets a dose, the missed dose should be taken as soon as remembered. The labeling specifies that a double dose should not be taken to make up for a missed dose.

Q: Can pregnant or breastfeeding individuals use Erix?

A: Erix is not indicated for use in women for Erectile Dysfunction. For Pulmonary Arterial Hypertension, data on use during pregnancy are insufficient to inform a drug-related risk. The active ingredient is noted to be excreted into human milk in very small amounts.

Q: Is Erix available in different forms (e.g., tablet, capsule)?

A: Official drug documents describe Erix as being supplied in multiple forms, including film-coated tablets, oral suspension, and oral solution. A capsule form is not typically listed in the standard regulatory descriptions of the product.

Q: What are the official guidelines for stopping Erix?

A: For continuous-use applications, regulatory guidelines describe that, to prevent potential sudden clinical deterioration during withdrawal, a gradual dose reduction should be considered by the prescriber. Intensified health monitoring is generally recommended during this period of discontinuation.

Q: What do patient groups usually say about their experience with Erix?

A: Official clinical studies on Erix frequently utilize patient-reported outcomes to measure results related to functional ability and symptom changes. These reported outcomes reflect patterns observed across groups of patients rather than individual patient experience.

Q: How does Erix compare generally to similar drugs I've heard about?

A: Erix belongs to the pharmacological class known as Phosphodiesterase type 5 (PDE5) inhibitors. Other medicines within this class share the same core principle of action, which is the selective blocking of the PDE5 enzyme.

Q: Can Erix be used by teenagers?

A: For the treatment of Erectile Dysfunction, Erix is not indicated for individuals under the age of 18. For Pulmonary Arterial Hypertension, the indication is established for pediatric patients, which includes those aged 1 to 17 years.

Q: Are the effects of Erix permanent after stopping the medicine?

A: No, the effects of Erix are temporary. The active substance is cleared from the body with a plasma half-life of approximately four to five hours. Once the medicine is stopped, the physiological effects are not considered permanent.

Q: Is Erix related to any other drug names I might see online?

A: The active ingredient in Erix, Sildenafil Citrate, is also marketed under other proprietary names for its specific approved uses, most commonly known as Viagra and Revatio.

Q: Does Erix have any potential effects on mood or sleep?

A: Official safety data lists certain effects involving the nervous system. These include Insomnia (difficulty sleeping) and Anxiety, which were both observed and classified as 'Common' adverse reactions in some patients.

Q: Is Erix available as a generic drug?

A: Yes, regulatory authorities have approved generic versions containing the active ingredient Sildenafil Citrate for the standard tablet dosage form.

Q: Is Erix considered addictive or habit-forming?

A: According to official government health agencies, Erix (Sildenafil Citrate) is not classified as a controlled substance and is not listed as having potential for abuse or dependence.

Q: What happens if Erix is taken with alcohol?

A: Official documentation notes that the co-administration of alcohol may enhance the vasodilatory effects of Erix. This effect is described as a transient decrease in blood pressure that could be associated with symptoms like dizziness or lightheadedness.

Q: Does Erix have a boxed warning in official documents?

A: Regulatory documents list specific Warnings and Precautions that highlight certain risks, but the product is not required to carry a Boxed Warning (Black Box Warning) in its labeling.

Q: Can Erix affect laboratory test results?

A: Studies have shown that the medicine may enhance the effects of certain substances that prevent blood clotting. In some patients, the effect on bleeding time was observed, which could potentially influence certain laboratory measurements.

Q: What is the function of the inactive ingredients in Erix?

A: The inactive ingredients (excipients) are included in the medicine to serve technical functions. These roles include facilitating the reliable delivery of the medicine, aiding in the reconstitution of liquid forms, and sometimes providing flavor or sweetness.

How should Erix be stored and disposed of?

Storage and Disposal Requirements for Erix

Official regulatory documents define strict conditions for storing and disposing of Erix to maintain product stability and safety. This information is non-advisory and label-based.

Storage Conditions

Requirement Official Statement
Temperature Store at 20, C to 25, C (Controlled Room Temperature). Do not freeze.
Protection Keep in the original container; protect from excessive moisture and heat.
Safety Keep out of the reach and sight of children at all times.

Disposal Instructions

Unused or expired Erix must be disposed of according to established governmental guidelines. It is prohibited to flush Erix down a toilet or pour it down a sink unless specifically authorized by the medication label. The product should be disposed of by utilizing an official drug take-back program or a medication collection point when available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Erix found in:

A-Z Index: